American Portfolios Advisors’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-11
Closed -$9.48K 3522
2021
Q3
$9.48K Buy
11
+8
+267% +$8.12K ﹤0.01% 2597
2021
Q2
$3.3K Hold
3
﹤0.01% 2989
2021
Q1
$2.85K Hold
3
﹤0.01% 2886
2020
Q4
$3.71K Hold
3
﹤0.01% 2533
2020
Q3
$1.83K Buy
+3
New +$2.18K ﹤0.01% 2642

Other funds holding CDLX

American Portfolios Advisors's CDLX Position: Q4 2021 in Review

American Portfolios Advisors sold out of Cardlytics (CDLX) in Q4 2021, closing a stake of 11 shares — an estimated $9.48K sold.

American Portfolios Advisors first reported a position in CDLX in Q3 2020 and held it in 5 quarters. The position peaked at $9.48K in Q3 2021. 163 funds tracked by Wall St. Rank hold CDLX as of Q4 2021.

  • American Portfolios Advisors reported no remaining Cardlytics position as of Q4 2021 after selling out during the quarter.
  • American Portfolios Advisors sold 11 Cardlytics shares in Q4 2021, an estimated $9.48K.
  • American Portfolios Advisors first reported a position in Cardlytics in Q3 2020 and held it in 5 quarters.
  • American Portfolios Advisors's Cardlytics position peaked at $9.48K in Q3 2021.
  • 163 funds tracked by Wall St. Rank held Cardlytics as of Q4 2021.

Based on American Portfolios Advisors's 13F filing for Q4 2021, filed 21 Mar 2023.